Results and updates covered here include positive news (at long last) from a developer of sustainable energy projects. Elsewhere, we are less impressed with results from a distributor of building materials, whose margins and strange mix of activities leave us scratching our heads. One of our Stonking Small Cap opportunities also continues to impress.
Advanced Medical: US regulatory approval
Advanced Medical Solutions (AIM: AMS), the world-leading specialist in tissue-healing technologies, has received US FDA approval for LiquiBand® XL, a new device that can close longer wounds than existing LiquiBand® products. The product launch into the US is expected in the third quarter of 2022 with strong demand for the new product from hospitals and the Group’s distribution partners.
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.
